Vaccination against Lyme disease appears to be safe and effective; however, the cost per quality-adjusted life-year (QALY) gained with vaccination is unknown. The authors developed a decision-analytical model to evaluate cost-effectiveness of vaccination compared with no vaccination in individuals living in endemic areas of Lyme disease.

Author names: 
Shadick, N.A.
Liang, M.H.
Phillips, C.B.
Fossel, K.
Kunz, K.M.
Year: 
2001
Publisher: 
Arch Intern Med 161(4) pp554-61.
Reference: 

Shadick, N.A., Liang, M.H., Phillips, C.B. K. Fossel and K.M. Kunz (2001) “The cost-effectiveness of vaccination against lyme disease” Arch Intern Med 161(4) pp554-61.

Geographical area: 
Scale: 
Policy areas considered: